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National Toxicology
Program: Landmarks
and the Road Ahead
The National Toxicology Program (NTP),
a cross-agency unit of the Department of
Health and Human Services (DHHS), is
one of the focal points for government
efforts aimed at generating, collecting, and
coordinating data used for guiding public
health decisions. Now 25 years old, the
NTP is in the middle of a strategic plan-
ning effort to define how it will integrate
new technologies with classical toxicologi-
cal approaches to continue providing,
according to the NTP’s motto, “good sci-
ence for good decisions.” 
In its current form, the NTP integrates
activities from the NIEHS, the National
Institute for Occupational Safety and
Health (NIOSH), and the
Food and Drug Admin-
istration (FDA) National
Center for Toxicological
Research (NCTR). Its mission is to evalu-
ate agents of public health concern by
developing and applying tools of modern
toxicology and molecular biology, a mis-
sion it achieves through the use of several
strategies. It designs studies on potential
toxicants and works with outside groups
and government labs to carry them out. It
reviews and evaluates what’s missing in
understanding environmentally induced
diseases. It then seeks to fill those gaps by
collaborating and cooperating with federal
agencies and with other domestic and for-
eign toxicology and public health organi-
zations, and by carrying out research itself
on human exposure and toxicity at labora-
tories housed at NIOSH and the NIEHS.
It supports grants, contracts, and intera-
gency agreements made through the
NIEHS Division of Extramural Research
and Training, and it supports the activities
of three centers. 
These activities have
brought immense gains in
knowledge for the scientific
community. But there is more
work still to do. Since the fall of 2003, the
NTP has been engaged in developing and
seeking public comment on a “roadmap”
to guide the program’s route forward over
the next decade. The roadmap seeks to
build on recent technological advances
that will allow toxicology to evolve from a
largely observational science to one that is
more predictive, and thus in many ways
more protective of public health. 
The Journey Begins
The NTP’s roots reach to the late 1960s,
when concerns over the effects of environ-
mental chemicals on human health began
to grow among scientists, policy makers,
public health officials, and the general
public. Books like Silent Spring began to
describe the relationship between
humankind and the rest of the world as
dangerously
out of balance.
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decade led to greater public awareness of
natural resources and the potentially
harmful effects of environmental pollu-
tion. As law makers and the public became
increasingly concerned about unforeseen
effects of chemicals all around us—partic-
ularly those used in manufacturing, agri-
culture, and household products such as
cleaners—new scientific and regulatory
approaches were enacted to better under-
stand these agents and decrease or elimi-
nate human exposure to harmful agents. 
Through the 1960s and 1970s, new
agencies were formed and responsibilities
within existing agencies were realigned in
efforts to understand, classify, and/or reg-
ulate compounds of concern. The Tox-
icology Information Program at the
National Library of Medicine began gath-
ering toxicological information and com-
piling data banks to allow searching and
comparison of the assembled material.
The NIEHS, which was
established in 1966 and
became a full NIH insti-
tute in 1969, started a
laboratory focused specifically on neuro-
toxicology in 1977, and in the same year
hosted one of the first conferences on
environmental estrogens. The Environ-
mental Protection Agency (EPA) was
founded in 1970 to pull environmental
and health protection activities from across
the government into one administrative
unit. The FDA took on licensing authority
for new biological therapeutic agents but
transferred its responsibility for oversight
of potentially hazardous materials and
other dangers in home items (such as toys,
furniture, clothing, and household chemi-
cal products) to the Consumer Product
Safety Commission (CPSC), which was
established in 1972.
In November 1978, Joseph Califano,
secretary of the Department of Health,
Education, and Welfare (the predecessor
of today’s DHHS), established the NTP as
a cooperative and coordinating effort
between agencies involved
in public health. The pro-
gram was seated at the
NIEHS and placed under
the leadership of then–NIEHS director
David Rall. Kenneth Olden assumed
directorship of both the NIEHS and the
NTP in 1991. Despite this link, the NTP
was and remains independent of the insti-
tute and of NIH. 
The new program’s charge included
coordinating toxicological testing pro-
grams within public health agencies;
strengthening the scientific basis of toxi-
cology; developing and validating new
assays and improved testing methods; and
providing information about potentially
toxic chemicals to health, regulatory, and
research agencies across the government,
to the scientific and medical communities,
and to the general public. 
Strengthening the Scientific Basis of
Toxicology
Among its earliest activities, the NTP
began collecting data from work going on
across federal agencies; by 1980 it had
generated a database comparing the results
gained from a variety of widely used geno-
toxicity assays. By the end of that year, the
program had issued its first Report on
Carcinogens (ROC), a scientific and public
health document identifying substances,
mixtures, and circumstances of exposure
that may lead to human cancers. The
ROC has been updated periodically since
then, and the eleventh edition is scheduled
for release late in 2004. 
In 1983, the NTP first developed and
began using five standard categories to
summarize the strengths of experimental
data produced by its own laboratories and
those of other agencies and industry in
studies of chemical or physical agents.
Four categories are based on a scale of
confidence that ranges from “clear evi-
dence” to “no evidence” of harm; a fifth
judges that evidence amounts to an “inad-
equate study.” The standardization helped
make the program’s long-term toxicity
reports—which can form the basis for pol-
icy recommendations on acceptable expo-
sure levels and use of chemicals—
more consistent across the range of
agents and exposures studied. So,
for example, when the State of
California passed Proposition 65,
the Safe Drinking Water and Toxic
Enforcement Act of 1986, NTP
data from the ROC were available
to help the state set standards for
discharge of potentially harmful
agents into drinking water. By 1987, the
NTP’s standardized categorization had
been used to classify conclusions from ear-
lier federal studies of potential hazards,
allowing the older information to be inte-
grated into current data sets. 
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cIn a paper in the 22 May 1987 issue of
Science, the NTP published the first com-
prehensive evaluation of genotoxicity
assays, laying the groundwork for a more
systematic approach to developing and
validating new in vitro assays. At the same
time, the program developed a battery of
tests for assessing chemically induced
immunotoxicity. As the 1980s drew to a
close, the NTP began developing trans-
genic mouse models for toxicology and
carcinogenicity testing, a new approach
that would allow easier detection of end
points such as tumors. (The NTP has con-
tinued to investigate the development of
transgenic animals as research tools, and in
2003 launched a new technical report
series to convey the findings from trans-
genic model systems.)
Revving Up in the 1990s 
The 1990s saw the NTP embark on a series
of new directions. One new effort, the
Predictive-Toxicology Evaluation Project,
was launched in 1990. Designed to use
chemical structures for direct prediction of
bioassay outcomes, the project published its
first results in the October 1996 issue of
EHP Supplements. Another new focus
evolved in 1992, when the FDA and the
NIEHS formed an interagency agreement
to coordinate and jointly fund a phototoxi-
cology research facility at the NCTR in
Jefferson, Arkansas. Existing laboratory
space at that facility was renovated in 1998
and 1999 to form a dedicated NTP Center
for Phototoxicology. The center works to
address the carcinogenic potential of chem-
icals when they are exposed to light or
applied to photo-treated skin. 
The NIH Revitalization Act of 1993
required that the NIH focus more on devel-
oping methods that lessen the use of
research animals, reduce pain and distress in
animals used, or avoid using animals alto-
gether. In 1997 Olden put together a cross-
agency panel, the Interagency Coordinating
Committee on the Validation of Alternative
Methods (ICCVAM), to implement the
act’s requirements. The committee was
made permanent in 2000 with the passage
of the ICCVAM Authorization Act. The
NTP Interagency Center for the Evaluation
of Alternative Toxicological Methods was
founded in 1998 at the NIEHS to provide
support for ICCVAM’s activities by holding
workshops and meetings, and by generating
reports. Through their efforts, the first alter-
native test acceptable to the EPA, the FDA,
and the Occupational Safety and Health
Administration, one for allergic contact der-
matitis, was established, significantly
decreasing the number of animals tested for
this end point. 
Through the 1990s, emerging public
interests led the NTP in new pursuits.
With the passage of the 1994 Dietary
Supplement Health and Education Act,
the NTP began looking at the potential for
toxicity and carcinogenicity of selected
dietary supplements, medicinal herbs, and
the compounds within them. The ROC
also saw some changes. The report was put
on a biennial publication schedule in
1993. The NTP’s nominations process, by
which federal and nongovernmental enti-
ties can recommend agents for testing, was
made clearer and more open to public
scrutiny. In addition, new criteria allowing
broader consideration of mechanistic data
were added to the ROC. 
A third NTP center, the Center for
the Evaluation of Risks to Human Repro-
duction, was established at the NIEHS in
1998. The center provides scientifically
based uniform assessments of the poten-
tial for reproductive and developmental
damage from human exposure to certain
toxicants. Expert panels convened by the
center evaluate evidence of reproductive
toxicity, determine patterns of chemical
use and human exposure, and develop sci-
entific consensus around tested agents’
capacity to harm humans. 
NTP workshops, conferences, and
reports in recent years have covered a
broad range of emerging and continuing
toxicological issues. The program has
addressed exposures of concern such as
methylmercury, acrylamide, and geneti-
cally modified foods. Researchers have
developed and validated technical meth-
ods for assessing human exposures, per-
forming dermal exposure studies in ani-
mals, and detecting endocrine disruptors.
And the program has brought researchers
together to build scientific consensus on
issues including how thyroid hormone
affects reproduction, approaches to select-
ing agents to study in transgenic mouse
models, and assessment of acute systemic
toxicity. 
Establishing a Roadmap for the
Future
In 2003, the NTP began to look at how it
could better position its activities to take
advantage of new technologies and address
a broader range of toxicological end points.
“The NTP has been in existence for twen-
ty-five years,” says Christopher Portier,
associate director of the program. “It was
time to look at what we’re doing and
decide if it’s still the right thing.” 
In fall 2003, the NTP’s advisory Board
of Scientific Counselors (BSC) developed
and approved a vision statement: “to sup-
port the evolution of toxicology from a
predominantly observational science at the
level of disease-specific models to a pre-
dominantly predictive science focused
upon a broad inclusion of target-specific,
mechanism-based, biological observa-
tions.” Three workgroups—one from the
NIEHS, one representing all of the federal
agencies served by the NTP, and one that
was a subcommittee of the BSC—then
contributed comments on what it would
take to make the vision a reality. Their
comments were incorporated into a
revised statement, which the NTP released
to the public in late 2003. At the same
time, the NTP announced a year-long
process to develop and seek public com-
ment on a “roadmap” for achieving the
vision. 
The NTP’s effort is not a part of, but
rather complements, NIH’s recently com-
pleted Roadmap for Medical Research.
The latter roadmap was aimed at identify-
ing critical gaps and opportunities in bio-
medical research that do not fit clearly
into the mission of any of the member
institutes. 
The process of developing the NTP
roadmap has been very open: the vision
and roadmap were discussed at a public
meeting at the NIH’s Bethesda campus in
January 2004; at a meeting of the NTP’s
Scientific Advisory Committee on Alter-
native Toxicological Methods held in
March; at a meeting of leading toxicolo-
gists held the same month at the conclu-
sion of the Society of Toxicology’s annual
meeting; at the June meeting of the BSC;
and at a retreat with advisors, stakeholders,
and federal agency staff in August. 
Those commenting were asked to
address what information the NTP should
be producing and what technical capacities
it should have at different points over the
next 10 years; how refinement and replace-
ment of classical toxicological studies with
mechanism-based assays will affect the
evaluation of public health hazards; how
the NTP can best be structured to provide
this information and ensure its optimal
utilization in the protection of public
health; and what resources and length of
time will be needed to realize this vision.
Early on, says Mark Toraason, a
NIOSH representative to the interagency
committee providing input on the
roadmap, the vision focused solely on turn-
ing toxicology on its head by moving it
from an observational science to a predic-
tive science. But because of perceived limi-
tations, the vision did not get immediate
buy-in from all stakeholders. “It was like,
‘Wait a minute, it may be NTP that gener-
ates that data, but it’s other government
agencies that use it. The other government
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need, and NTP should meet those needs,’”
says Toraason. “There has been a meeting
of the minds there, and the roadmap has
been modified with the recognition put in
that the needs of the other government
agencies can continue to be met as the
vision is attained.” 
Short-term goals (to be accomplished
in the next five years) include a number of
workshops to set priorities and working
strategies. Basic study design, from choice
of model organism strain and species to
duration of experiments, will be re-evalu-
ated, and gaps where current study
designs or the current knowledge base fall
short will be addressed. NTP staff and
advisors will interact with policy makers
to build better tools for analyzing risks
and setting standards. Proof-of-principle
studies will be conducted with new and
revamped assays, and new data infrastruc-
ture and data management tools will be
built. Work toward improving the NTP’s
use of high-throughput screening will
include cataloguing approaches being used
in the public domain and applying these
assays to more than 500 agents that have
already gone through the full two-year
bioassay that is the NTP’s current gold
standard.
Long-term goals (to be accomplished
over the next 10 years) are ambitious—val-
idating the use of new kinds of assays for
regulatory decision making, prioritizing
compounds for toxicity testing, evaluating
human relevance, and addressing specific
diseases. In the long run, the NTP aims to
develop and validate a battery of predictive
tests and a systematic understanding of the
metabolism of toxicants. The plan also
calls for banking tissue samples from NTP
studies and panels of tested agents, which
would be available to the extramural
research community by 2010.
Wheels of Change
With rapidly developing technologies cre-
ating new opportunities for doing better
science faster, application of high-
throughput approaches—including whole-
genome analysis and work that builds on
genomic data—is a critical part of the
roadmap. These new approaches show
great promise for solving a central prob-
lem: the sheer volume of chemicals that
must be characterized and tested. Various
estimates put the number of chemicals in
commerce in the tens of thousands;
Portier says such estimates are almost cer-
tainly an understatement. “We can’t possi-
bly test everything,” he says. EPA scientist
and Society of Toxicology president Linda
Birnbaum puts it another way: “We can’t
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Headliners Maternal Nutrition and 
Child Cancer
NIEHS-Supported Research
Mother’s Pre-pregnancy Diet May Influence Child Cancer Risk
Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S. 2004. Maternal dietary risk fac-
tors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control
15(6):559–570.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer
(with 2,400 cases diagnosed each year in those under age 20) and the second
most common cause of mortality in children aged 1–14. Recent research has
confirmed that ALL can originate in utero. New findings from the NIEHS-
funded Northern California Childhood Leukemia Study (NCCLS) show that the
disease may originate even earlier—in the foods a woman eats before she
even becomes pregnant. 
The effect of maternal diet on child leukemia risk has not been rigorous-
ly studied; the few studies that have been done have focused on specific
dietary factors, and the results have been mixed. The NCCLS is a population-
based case–control study of risk factors for child leukemia, including maternal
diet. It is the first study to capture mothers’ overall dietary patterns and relate
them to child leukemia.
Researchers compared 138 mothers of children diagnosed with ALL with
a control group of 138 mothers whose children did not have cancer. All the
mothers completed a questionnaire pertaining to their diet in the 12 months
prior to pregnancy. The researchers chose this period as a more accurate
reflection of each woman’s typical diet, compared to pregnancy, when diet
can vary with the degree of nausea experienced. The questionnaire asked
about 76 food items, plus use of vitamins, certain reduced-fat foods, and
cooking fat.
The researchers found that the more vegetables, fruits, and proteins a
woman ate, the lower the risk of her child having leukemia. Of the vegetables
and fruits, carrots and cantaloupe showed the highest inverse effect, perhaps
because of these foods’ high carotenoid content. String beans and peas also
correlated inversely with ALL risk. Among the proteins, beef and beans—both
sources of the antioxidant glutathione—showed the highest inverse effect.
Use of vitamin supplements was not significantly linked to leukemia risk.
The authors stress that dietary factors work together, and no one food
should be singled out in attributing risk or benefit. Further, a cause-and-
effect relationship can not be concluded from this study. However, they
write, it remains prudent for women who are pregnant or think they may
become pregnant to eat a diet rich in fruits and vegetables. –Susan M. Bookerkeep doing more and more and more tests
on more and more and more chemicals.
We have to be able to test smarter, not
necessarily more.”
“I think we can double, triple, quadru-
ple, tenfold the number of things we look
at if we’re intelligent about how we
approach it,” Portier says. He explains using
an example from the world of industry: “In
developing a new drug, the pharmaceutical
industry scans a very large number of chem-
ical entities in some very simple assays.
From that, they choose a smaller set that
they test in medium-throughput assays, and
from that they choose one or two that they
test in animals. That’s the direction I want
to see us going.” 
But moving in new directions isn’t
easy, and incorporating new technologies
into the NTP’s suite of well-accepted
assays provides one of the biggest chal-
lenges. “One of the problems with devel-
oping totally new methods is when you do
something new, it has to be replicated,
which means that the expertise and the
work have to be going on in a number of
different laboratories,” says George
Daston, a research fellow at Procter and
Gamble and member of the BSC. 
Validation of the assays developed
around new technologies will be critical.
“The technology is quite enticing and it’s
razzle-dazzle, but we always have to be able
to bring it back to the reality of biology
and what it means for the whole organism,
and especially what it means for human
risk,” says Samuel Cohen, a professor at
the University of Nebraska Medical Center
in Omaha and BSC member. “This needs
to be an evolutionary process rather than a
revolutionary process.”
Reduction, refinement, and replace-
ment of animal use may be one of the areas
where this evolution first appears.
Currently the NTP favors the two-year
animal bioassay as its assay of choice. Yet
adding more analyses to the experiments
currently being done could help, says
Cohen: “There is a considerable amount
that can be gained, not only from the ani-
mals during the two-year process, but also
in the preliminary studies—the four-week
and thirteen-week studies that are done
ahead of time—that could be of more pre-
dictive value, so that we didn’t have to do
as much in the two-year study ultimately,
if at all.”
All for One and One for All
Data sharing will help bring stakeholders
together. The NTP intends to eventually
make its chronic assay database and other
databases publicly available, which Tor-
aason says will help with communication,
not just to the public but also across federal
agencies. “In the past it could be difficult to
get information from NTP at times,” he
explains. “You needed a reliable contact
and had to know who knew what and so
on. Now their website contains a wealth of
searchable information, and the intent is to
increase the amount of information that is
publicly available.”
The extramural research community
will have access to all these public data and
can expect to play new roles if the
roadmap is put in place, but it’s not yet
clear how they will be involved. “We
talked about a large number of possibili-
ties,” Portier says, “from providing the
extramural community with NTP tissues
from NTP studies to do their own
research, to providing them with arrays of
chemicals if someone has their own high-
throughput facility, to setting up centers
for doing toxicological screenings toward
mechanisms, and a number of other differ-
ent possibilities.” 
The work of extramural scientists will
be needed and appreciated. “We don’t
have all the answers, we don’t know how
to analyze all the data, we don’t know
what it all means, and I’m not sure I have
the staff on hand to do all that,” Portier
says. “The only way it’s going to actually
happen is if the public has access to the
data. It’s going to be scientists at universi-
ties who come out and get NIEHS grants
to analyze our data and give us some inter-
pretation tools that really lead that effort.” 
James Popp, a BSC member and
cofounder of the consulting group
Stratoxon, has worked in academe, govern-
ment, and industry. He says there’s a
much greater openness among those three
realms to talking and working together
than he’s seen in a long time. “There’s
been this mind-set change, and I think
that’s important to opening up these dia-
logues,” he says. “We’re in an era of very
rapid technological changes, and so it’s a
matter of capturing that opportunity of
mind-set changes, technology changes, and
new advancements in basic knowledge of
biology.” 
This greater accord between sectors
raises some concerns, though, according to
Jennifer Sass, a senior scientist for the
Natural Resources Defense Council, an
environmental advocacy group. “The colle-
gial familiarity that’s being set up leads to a
lot of questions,” she says. “The problem is
that industry clearly sees a triangle includ-
ing government, academia, and them-
selves, and there is no public interest, no
public watchdog groups, in the picture.” 
Other opinions vary. “NTP has done a
good job of informing just about everybody
in the scientific community about what
they’re doing. They have listened to the
criticisms, and have expanded the vision
accordingly,” Toraason says. 
Still, the public does need to be
informed, says Popp, and that will take
better efforts at communications. “There
are multiple audiences,” he explains.
“Obviously, there’s the political audience,
but it’s more than that—it’s a broader
societal audience that needs to be
addressed, and the general public does not
have a good grasp of basic scientific princi-
ples in toxicology or anything else. So
there’s a very large educational process that
needs to go along with the scientific work
in the roadmap.”
The Road Ahead
The roadmap sets an ambitious course for
the next decade. But is it achievable? “[The
NTP has] to recognize that what they put
out is a vision, very broad and somewhat
all-encompassing,” says Michael Hol-
sapple, executive director of the Health
and Environmental Sciences Institute of
the International Life Sciences Institute, an
industry-funded nonprofit that works to
enhance the scientific basis for public
health decision making. Holsapple recom-
mends “partnering, being judicious, and
recognizing that their map is a good first
step.” But in reality, he says, “when the
rubber hits the road, they can’t do it all.” 
Portier sees it differently. “Partnerships
will be an important part of the initiatives
outlined in the roadmap,” he says. “While
the NTP has the budget necessary to
address all of the aspects of the roadmap, it
will require a concerted effort from all of
the NTP stakeholders to develop the tools
that will allow us to understand and use
this new information in addressing public
health priorities.” 
Everything could change with the
arrival of a new director. Olden has
announced he will leave his positions as
NTP and NIEHS director in the near
future, though he will continue to serve
until his successor is appointed. “If the
new director comes in and doesn’t like
[our plan], then we sit down and think
about where we’re going to go and how
we’re going to get there based upon his or
her vision of what the NTP should be
doing,” Portier says. “But the advice we’ve
gotten is still excellent advice, and it will
help to chart whatever course we eventual-
ly take.” –Victoria McGovern
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For More Information
http://ntp.niehs.nih.gov/Problems along the
New “Silk Road”
The inexpensive sweater you buy in New
Jersey, the bargain dresser you buy in
Wisconsin, and the low-cost toys you buy
in Ohio all have one thing in common:
most likely they were made in Asia, and
chances are they entered the United States
through a Southern California port.
These consumer goods may be easy on
the pocketbook, and thriving internation-
al trade may be good for the economy,
but the environment is seeing some seri-
ous impacts. Today the NIEHS-funded
Southern California Environmental
Health Sciences Center (SCEHSC) is
working to raise awareness about these
impacts. The center is a partnership
between investigators at the University of
Southern California and the University of
California, Los Angeles. 
The adjacent twin ports of Los
Angeles and Long Beach have become the
world’s third largest port complex, flood-
ing the region with imported cargo con-
tainers, which are transported
by big-rig diesel trucks and
by ships and freight trains
operating on low-grade fuel.
The booming trade has made
the ports the region’s num-
ber-one source of air pollu-
tion. And the ports keep
growing, creating a need for
expanded freeways and larger
intermodal facilities where
containers are moved from
trucks onto trains. 
Emissions from foreign-
flagged ships (nearly all ships
entering the two ports) are
currently unregulated, consti-
tuting a major concern for
residents in the port commu-
nities. Residents along truck-
congested freeways and rail
routes are also impacted.
“We have homes and parks
right next to the rail yard,”
says Angelo Logan, director
of the grassroots organization
East Yard Communities for
Environmental Justice, “and
sometimes locomotives idle
here for hours.” 
The SCEHSC, spurred by
community concerns raised
at a 2001 Town Meeting it sponsored,
has been dedicating significant attention
to these global trade impacts. Through
the center’s Community Outreach and
Education Program, center investigators
and outreach staff are raising awareness of
the need to reduce trade-related air pollu-
tion and better protect residents from the
surge in such pollution. 
Center investigators and
outreach staff have present-
ed data to elected officials
on air pollution’s respi-
ratory effects on chil-
dren. Among these are
the results of the 10-
year longitudinal Chil-
dren’s Health Study
(directed by SCEHSC
director John Peters),
which shows a larger propor-
tion of children in more polluted
communities suffering lung function
deficits, with lifelong health significance.
Staff have also testified on the health effects
of exposure to diesel exhaust at hearings to
ban idling of diesel trucks at the ports, to
triple the capacity of a freeway that goes
through dozens of low-income, primarily
Latino communities, and to construct huge
trucking distribution centers in Riverside,
one of the country’s most polluted cities. 
Center member Ed Avol serves as an
appointee to the Mayor of Los Angeles’
special task force on port emissions,
which was convened in October 2004.
The center recently published a policy
brief looking at the need to place a higher
priority on health when key development
decisions are made—for example, in
regards to expansion of ports, rail
yards, freeways, or warehouses.
And center member John
Froines and outreach director
Andrea Hricko discussed
the impacts of global trade
on local communities at
the November 2003 round-
table discussion “Global-
ization, International Trade,
and Environmental Health,”
sponsored by the Institute
of Medicine of the National
Academies.
Center staff are also working directly
with community members, for example
by taking high school and college students
on tours of the ports and teaching them
how to take ultrafine particle measure-
ments. The center is also cosponsoring a
Town Meeting in February 2005 with a
theme of “Local and Regional Health
Impacts of the Ports and Global Trade.”
–Andrea M. Hricko
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The high price of cheap goods. Container ships bring inexpensive goods from around the world into the Port of Los
Angeles, but the pollution caused by transportation of these goods by ship, truck, and train has human health costs.